We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Clues into How Cells Achieve Immortality

By LabMedica International staff writers
Posted on 28 Apr 2010
Swedish investigators can now show that cells that grow forever, becoming immortal, obtain this capacity through gradual changes in the expression of genes that control the repair of DNA damage and regulate growth and cell death. More...
Their research also shows that activation of the enzyme complex telomerase, which is essential for unlimited growth, occurs late in this process.

The study's findings, published in the April 2010 issue of the journal Aging Cell, was performed by a research team from Umeå University (Sweden) and directed by Prof. Göran Roos at the department of medical bioscience, pathology. The study's findings provide more insights into how cells' telomeres are regulated during the process that leads to perpetuating the life of cells.

One type of blood cells, lymphocytes, were analyzed on repeated occasions during their cultivation in an incubator until they achieved the ability to grow an unlimited number of cell divisions, a process that is termed immortalization. In experiments, immortalization can be achieved following genetic manipulation of cells in various ways, but in the lymphocytes under study, this occurred spontaneously. This is an atypical phenomenon that can be compared to the development of leukemia in humans, for example.

The ends of chromosomes, the telomeres, are important for the genetic stability of organisms' cells. In normal cells, telomeres are shortened with every cell division, and at a specific short telomere length, they stop dividing. With the occurrence of genetic mutations, the cells can continue to grow even though their telomeres continue to be shortened. At a critically short telomere length, however, a so-called crisis occurs, with imbalance in the genes and massive cell death. In rare cases, the cells survive this crisis and become immortalized. In earlier research, this transition from crisis to eternal life has been associated with the activation of telomerase, an enzyme complex that can lengthen cells' telomeres and help stabilize the genes. A typical finding is that cancer cells have active telomerase.

The current study demonstrated that cells initially lose telomere length with each cell division, as expected, and after a while enter a crisis stage with massive cell death. Those cells that survive the crisis and become immortalized evince no activation of telomerase; instead, this happens later in the process. The Umeå researchers discovered that the expression of genes inhibiting telomerase is reduced in cells that get through the crisis, but telomerase was not activated until positively regulating factors were activated, thus allowing the telomeres to become stabilized through lengthening. By analyzing the genetic expressions, the scientists were able to show that the cells that survived the crisis stage had mutations in genes that are crucial to the repair of DNA damage and the regulation of growth and cell death. This discovery provides new insights into the series of events that needs to occur for cells to become immortalized, and it will have an impact on future studies of leukemia, for example.

The studies were performed in collaboration with the Center for Oncology and Applied Pharmacology, University of Glasgow (UK) and the Maria Skodowska-Curie Memorial Cancer Center and Institute of Oncology (Warsaw, Poland).

Related Links:
Umeå University


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.